UA88655C2 - S-миртазапин для лечения прилива крови - Google Patents

S-миртазапин для лечения прилива крови

Info

Publication number
UA88655C2
UA88655C2 UAA200705135A UAA200705135A UA88655C2 UA 88655 C2 UA88655 C2 UA 88655C2 UA A200705135 A UAA200705135 A UA A200705135A UA A200705135 A UAA200705135 A UA A200705135A UA 88655 C2 UA88655 C2 UA 88655C2
Authority
UA
Ukraine
Prior art keywords
mirtazapine
treatment
hot flush
flush
hot
Prior art date
Application number
UAA200705135A
Other languages
English (en)
Ukrainian (uk)
Inventor
Б.В.М.М. Бернардус Петерс
Антон Эгберт Петер Аданг
Original Assignee
Н.В. Органон
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA88655(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Н.В. Органон filed Critical Н.В. Органон
Publication of UA88655C2 publication Critical patent/UA88655C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Изобретение относится к медицине и касается способа лечения прилива крови медикаментом, который содержит как активную составляющую чистый S-миртазапин. Изобретение также касается применения S-миртазапина для производства медикамента для лечения прилива.
UAA200705135A 2004-11-15 2005-11-14 S-миртазапин для лечения прилива крови UA88655C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15

Publications (1)

Publication Number Publication Date
UA88655C2 true UA88655C2 (ru) 2009-11-10

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200705135A UA88655C2 (ru) 2004-11-15 2005-11-14 S-миртазапин для лечения прилива крови

Country Status (31)

Country Link
US (4) US20070265245A1 (ru)
EP (1) EP1814555B1 (ru)
JP (1) JP2008519810A (ru)
KR (1) KR20070085470A (ru)
CN (2) CN102772414A (ru)
AR (1) AR053780A1 (ru)
AT (1) ATE439843T1 (ru)
AU (1) AU2005303778B2 (ru)
BR (1) BRPI0517818A2 (ru)
CA (1) CA2587283C (ru)
CY (1) CY1110538T1 (ru)
DE (1) DE602005016141D1 (ru)
DK (1) DK1814555T3 (ru)
ES (1) ES2329815T3 (ru)
HK (1) HK1104235A1 (ru)
HR (1) HRP20090513T1 (ru)
IL (1) IL182767A (ru)
MX (1) MX2007005827A (ru)
MY (1) MY144089A (ru)
NO (1) NO20072285L (ru)
NZ (1) NZ554858A (ru)
PE (1) PE20061051A1 (ru)
PL (1) PL1814555T3 (ru)
PT (1) PT1814555E (ru)
RS (1) RS51138B (ru)
RU (1) RU2396957C2 (ru)
SI (1) SI1814555T1 (ru)
TW (1) TW200631584A (ru)
UA (1) UA88655C2 (ru)
WO (1) WO2006051111A1 (ru)
ZA (1) ZA200703884B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002174A2 (en) * 2005-06-27 2007-01-04 N.V. Organon. A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
WO2007101832A1 (en) * 2006-03-06 2007-09-13 N.V. Organon An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
AU2007324467A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów
CN110996947A (zh) * 2017-05-25 2020-04-10 格莱泰施有限责任公司 N-甲基-d-天冬氨酸型谷氨酸受体拮抗剂反应性神经精神性疾病的联合治疗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
WO1999051237A1 (en) * 1998-04-02 1999-10-14 Akzo Nobel N.V. Oral liquid antidepressant solution

Also Published As

Publication number Publication date
US20120302552A1 (en) 2012-11-29
WO2006051111A1 (en) 2006-05-18
ZA200703884B (en) 2009-07-29
RU2396957C2 (ru) 2010-08-20
HK1104235A1 (en) 2008-01-11
PL1814555T3 (pl) 2010-01-29
PT1814555E (pt) 2009-09-30
CY1110538T1 (el) 2015-04-29
KR20070085470A (ko) 2007-08-27
IL182767A (en) 2011-07-31
MY144089A (en) 2011-08-15
SI1814555T1 (sl) 2009-12-31
NZ554858A (en) 2009-10-30
EP1814555B1 (en) 2009-08-19
RS51138B (sr) 2010-10-31
CN102772414A (zh) 2012-11-14
CA2587283C (en) 2013-01-15
PE20061051A1 (es) 2006-10-26
AU2005303778B2 (en) 2011-02-17
RU2007122391A (ru) 2008-12-20
DK1814555T3 (da) 2009-12-07
NO20072285L (no) 2007-06-13
ES2329815T3 (es) 2009-12-01
CN101056641A (zh) 2007-10-17
CA2587283A1 (en) 2006-05-18
BRPI0517818A2 (pt) 2010-03-16
JP2008519810A (ja) 2008-06-12
US20100267694A1 (en) 2010-10-21
US20070265245A1 (en) 2007-11-15
EP1814555A1 (en) 2007-08-08
TW200631584A (en) 2006-09-16
AR053780A1 (es) 2007-05-23
IL182767A0 (en) 2007-09-20
HRP20090513T1 (en) 2009-10-31
MX2007005827A (es) 2007-07-20
AU2005303778A1 (en) 2006-05-18
DE602005016141D1 (de) 2009-10-01
ATE439843T1 (de) 2009-09-15
US20130225559A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
UA88655C2 (ru) S-миртазапин для лечения прилива крови
IL183963A0 (en) 1 - aminocyclohexane - derivatives for the treatment of multiple sclerosis, emotional liability and pseudobulbar affect
IL244803B (en) Human anti-beta antibodies and their use
TW200738270A (en) Method of treating depression using a TNFα antibody
AP2327A (en) Quinoline derivatives for the treatment of latent tuberculosis.
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
CA119341S (en) Goggle
WO2007146426A3 (en) Nanoshells for drug delivery
EP1771188A4 (en) METHOD AND COMPOSITIONS FOR TREATING ADIPOSITAS, INSULINED DISEASES AND HYPERCHOLESTERINEMIA
IL179515A0 (en) Method of administering and using vegf inhibitors for the treatment of human cancer
CA117908S (en) Inhaler
EP2046973A4 (en) METHODS OF IDENTIFYING, EVALUATING, AND TREATING PATIENTS SUBJECTED TO ANTICANCER THERAPY
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
TW200628156A (en) Combination of a SRC kinase inhibitor and a BCR-ABL inhibitor for the treatment of proliferative diseases
WO2010077589A3 (en) Stat3 inhibitors and therapeutic methods using the same
IL178827A0 (en) Use of reboxetine for the treatment of pain
PT1713438E (pt) Sabonete medicinal
CA117351S (en) Iron
HK1103006A1 (en) Medical plaster for application on the skin
GB0411014D0 (en) Methods for the control treatment and management of obesity
MX2007004040A (es) Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.
CA117204S (en) Iron
UA11522U (ru) Способ профилактики гнойно-воспалительных осложнений родовых травм промежности
CA117753S (en) Air deodorising apparatus
HK1062808A1 (en) An external use drug for treating hemorrhoids and methods for preparing the same.